Alberta Health Services, Holy Cross Site

Calgary, Alberta T2S 3C3

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung

Studies at this site

• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed